Endometrial cancer rates are rising — the symptom most women don't report early enough

Unlike several other major cancers, endometrial cancer incidence has been climbing steadily, and the one symptom that should prompt fast evaluation is often dismissed as ordinary irregular bleeding.

Endometrial cancer — cancer of the uterine lining — has been rising in incidence for years, in contrast to the declining or stable trends seen in several other major cancers, a rise researchers largely attribute to increasing rates of obesity, since excess adipose tissue produces estrogen that stimulates endometrial tissue growth, along with an aging population and, in more recent analysis, rising rates specifically among younger and non-white women where the increase has been particularly pronounced and less fully explained by the obesity trend alone.

Unlike ovarian cancer, which has historically lacked reliable early symptoms, endometrial cancer usually does produce an early warning sign: abnormal uterine bleeding, particularly any bleeding after menopause, or significantly irregular or heavy bleeding in a premenopausal woman outside her normal pattern. This symptom specificity is actually a real advantage for early detection — the problem is that it's frequently dismissed or attributed to perimenopause, fibroids, or stress rather than prompting prompt evaluation, especially in women without other obvious risk factors.

There's no routine screening test for endometrial cancer the way there is for cervical or breast cancer in average-risk women — the postmenopausal bleeding symptom itself functions as the primary trigger for evaluation, typically starting with a transvaginal ultrasound to measure the uterine lining thickness, followed by a biopsy if the finding is concerning, which is part of why any postmenopausal bleeding, regardless of how light or brief, warrants prompt medical evaluation rather than being written off.

For any postmenopausal bleeding, or significantly abnormal bleeding in a premenopausal woman that's outside her normal pattern, prompt evaluation rather than a wait-and-see approach is the practical takeaway the rising incidence trend and the symptom's genuine predictive value both support — this is one of the more reliably early-detectable gynecologic cancers precisely because the primary symptom tends to show up before the disease has progressed far.

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.

More in Cancer Screening & Prevention

Lung cancer screening guidelines: who qualifies for low-dose CT Colorectal cancer screening age changes explained The difference between screening and diagnostic tests

Endometrial cancer rates are rising — the symptom most women don't report early enough

Unlike several other major cancers, endometrial cancer incidence has been climbing steadily, and the one symptom that should prompt fast evaluation is often dismissed as ordinary irregular bleeding.

This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.